This federal contract award, with identification number SPE2DB22D3501|SPE2DB25FTX39, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $5,033.56 firm fixed-price delivery order is for the supply of 4566789320 - Hydralazine 20 mg/ml vial, a pharmaceutical product used in the treatment of various medical conditions. The contract has an ultimate completion date of December 24, 2024.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be part of that larger IDC contract with the DLA. The contract does not have a set-aside designation, indicating open competition.
Generated 3/24/25, 9:47 AM